Elevance Health Inc.
Elevance Health Inc.（ELV）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ELV · 截至 2026年6月8日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
3
近12个月
买卖比
1.67
Buy/Sell (by trades)
整体情绪
Elevance Health Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ELV 季度内部人买卖趋势
ELV 内幕交易卖出 · ELV 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ELV CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ELV 高管卖出股份 · ELV 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 19, 2026 | Penczek Ronald W CAO & Controller | Option | 877 | $273K | Form 4 |
| May 19, 2026 | Penczek Ronald W CAO & Controller | Option | 654 | $177K | Form 4 |
| May 19, 2026 | Penczek Ronald W CAO & Controller | Sale | 1,531 | $617K | Form 4 |
| May 13, 2026 | STRABLE-SOETHOUT DEANNA D Director | Award | 563 | — | Form 4 |
| May 13, 2026 | SCHULMAN AMY W Director | Award | 563 | — | Form 4 |
| May 13, 2026 | Schneider Ryan M. Director | Award | 563 | — | Form 4 |
| May 13, 2026 | PERU RAMIRO G Director | Award | 563 | — | Form 4 |
| May 13, 2026 | Neri Antonio F Director | Award | 563 | — | Form 4 |
| May 13, 2026 | Jallal Bahija Director | Award | 563 | — | Form 4 |
| May 13, 2026 | HAY LEWIS III Director | Award | 563 | — | Form 4 |
| May 13, 2026 | Dixon Robert L JR Director | Award | 563 | — | Form 4 |
| May 13, 2026 | DeVore Susan D. Director | Award | 563 | — | Form 4 |
| May 13, 2026 | COLLIS STEVEN H Director | Award | 563 | — | Form 4 |
| Mar 12, 2026 | SCHULMAN AMY W Director | Sale | 26 | $7K | Form 4 |
| Mar 6, 2026 | Kendrick Charles Morgan JR EVP & President, Commercial | Sale | 3,196 | $911K | Form 4 |
| Mar 5, 2026 | COLLIS STEVEN H Director | Purchase | 3,000 | $870K | Form 4 |
| Mar 2, 2026 | Penczek Ronald W CAO & Controller | Award | 266 | — | Form 4 |
| Mar 3, 2026 | Penczek Ronald W CAO & Controller | Other | 37 | $11K | Form 4 |
| Mar 2, 2026 | Penczek Ronald W CAO & Controller | Award | 1,701 | — | Form 4 |
| Mar 2, 2026 | Penczek Ronald W CAO & Controller | Award | 426 | — | Form 4 |
| Mar 2, 2026 | Penczek Ronald W CAO & Controller | Other | 131 | $39K | Form 4 |
| Mar 2, 2026 | Wessling Erin M EVP & Chief Legal Officer | Award | 2,976 | — | Form 4 |
| Mar 3, 2026 | Wessling Erin M EVP & Chief Legal Officer | Other | 417 | $118K | Form 4 |
| Mar 2, 2026 | Craig Ryan R EVP & Chief HR Officer | Award | 2,976 | — | Form 4 |
| Mar 3, 2026 | Craig Ryan R EVP & Chief HR Officer | Other | 309 | $88K | Form 4 |
Kendrick Charles Morgan JR
EVP & President, Commercial
日期
Mar 6
股数
3,196
均价
$284.92
总金额
$911K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ELV 内幕交易
ELV 内幕交易
Elevance Health Inc.（ELV）内幕交易数据来源于公司内部人（包括Penczek Ronald W (CAO & Controller), BOUDREAUX GAIL (President and CEO · Director), Kendrick Charles Morgan JR (EVP & President, Commercial)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ELV内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Elevance Health Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ELV 内幕交易 · 5个问题Elevance Health Inc.（ELV）的内部人包括高管和董事，如Penczek Ronald W (CAO & Controller), BOUDREAUX GAIL (President and CEO · Director), Kendrick Charles Morgan JR (EVP & President, Commercial)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026